rs117412802

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001846.4(COL4A2):​c.3368A>G​(p.Glu1123Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0118 in 1,599,498 control chromosomes in the GnomAD database, including 156 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E1123D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0098 ( 13 hom., cov: 33)
Exomes 𝑓: 0.012 ( 143 hom. )

Consequence

COL4A2
NM_001846.4 missense

Scores

9
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10O:1

Conservation

PhyloP100: 3.57

Publications

21 publications found
Variant links:
Genes affected
COL4A2 (HGNC:2203): (collagen type IV alpha 2 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. The C-terminal portion of the protein, known as canstatin, is an inhibitor of angiogenesis and tumor growth. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jul 2008]
COL4A2 Gene-Disease associations (from GenCC):
  • porencephaly 2
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • COL4A1 or COL4A2-related cerebral small vessel disease
    Inheritance: AD Classification: MODERATE Submitted by: Illumina
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010744929).
BP6
Variant 13-110491254-A-G is Benign according to our data. Variant chr13-110491254-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 29629.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00979 (1490/152212) while in subpopulation NFE AF = 0.0139 (946/68006). AF 95% confidence interval is 0.0132. There are 13 homozygotes in GnomAd4. There are 743 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 1490 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A2NM_001846.4 linkc.3368A>G p.Glu1123Gly missense_variant Exon 37 of 48 ENST00000360467.7 NP_001837.2 P08572A0A024RDW8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A2ENST00000360467.7 linkc.3368A>G p.Glu1123Gly missense_variant Exon 37 of 48 5 NM_001846.4 ENSP00000353654.5 P08572

Frequencies

GnomAD3 genomes
AF:
0.00980
AC:
1490
AN:
152094
Hom.:
13
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00229
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00629
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00332
Gnomad FIN
AF:
0.0297
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0139
Gnomad OTH
AF:
0.00766
GnomAD2 exomes
AF:
0.00910
AC:
2047
AN:
224932
AF XY:
0.00932
show subpopulations
Gnomad AFR exome
AF:
0.00223
Gnomad AMR exome
AF:
0.00378
Gnomad ASJ exome
AF:
0.00293
Gnomad EAS exome
AF:
0.0000589
Gnomad FIN exome
AF:
0.0245
Gnomad NFE exome
AF:
0.0124
Gnomad OTH exome
AF:
0.0102
GnomAD4 exome
AF:
0.0121
AC:
17461
AN:
1447286
Hom.:
143
Cov.:
31
AF XY:
0.0119
AC XY:
8535
AN XY:
718390
show subpopulations
African (AFR)
AF:
0.00169
AC:
56
AN:
33126
American (AMR)
AF:
0.00351
AC:
152
AN:
43362
Ashkenazi Jewish (ASJ)
AF:
0.00337
AC:
87
AN:
25810
East Asian (EAS)
AF:
0.000204
AC:
8
AN:
39218
South Asian (SAS)
AF:
0.00362
AC:
303
AN:
83668
European-Finnish (FIN)
AF:
0.0272
AC:
1424
AN:
52446
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5752
European-Non Finnish (NFE)
AF:
0.0134
AC:
14808
AN:
1104110
Other (OTH)
AF:
0.0102
AC:
612
AN:
59794
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
748
1496
2245
2993
3741
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
542
1084
1626
2168
2710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00979
AC:
1490
AN:
152212
Hom.:
13
Cov.:
33
AF XY:
0.00998
AC XY:
743
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.00229
AC:
95
AN:
41528
American (AMR)
AF:
0.00628
AC:
96
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00332
AC:
16
AN:
4816
European-Finnish (FIN)
AF:
0.0297
AC:
315
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0139
AC:
946
AN:
68006
Other (OTH)
AF:
0.00758
AC:
16
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
75
150
226
301
376
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0109
Hom.:
33
Bravo
AF:
0.00725
TwinsUK
AF:
0.0146
AC:
54
ALSPAC
AF:
0.0138
AC:
53
ESP6500AA
AF:
0.00223
AC:
9
ESP6500EA
AF:
0.0134
AC:
112
ExAC
AF:
0.00783
AC:
945
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:7
Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

COL4A2: BS1, BS2 -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 09, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 28, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 32172663, 22209247, 25719457, 24390199) -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Porencephaly 2 Benign:2
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Hemorrhage, intracerebral, susceptibility to Other:1
Jan 13, 2012
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.16
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.71
D
Eigen
Uncertain
0.37
Eigen_PC
Uncertain
0.38
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.52
T
MetaRNN
Benign
0.011
T
MetaSVM
Uncertain
0.25
D
MutationAssessor
Uncertain
2.1
M
PhyloP100
3.6
PrimateAI
Benign
0.36
T
PROVEAN
Uncertain
-3.4
D
REVEL
Uncertain
0.47
Sift
Benign
0.081
T
Sift4G
Benign
0.098
T
Polyphen
0.96
D
Vest4
0.77
MVP
0.93
MPC
0.88
ClinPred
0.018
T
GERP RS
5.0
Varity_R
0.18
gMVP
0.85
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117412802; hg19: chr13-111143601; API